Medical/Pharmaceuticals
Lynx Analytics Unveils LynxKite 2000:MM - The Next Generation of GPU-Optimized Graph AI
LOS GATOS, Calif., March 19, 2025 /PRNewswire/ -- Lynx Analytics, a member of
theNVIDIA Inception
2025-03-19 21:00
2216
Henlius Receives Orphan Drug Designation for Innovative Anti-HER2 mAb HLX22 in the U.S. for Gastric Cancer
SHANGHAI, March 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal antibody (mAb) for the treatment of gastric cancer. Ac...
2025-03-19 21:00
2485
Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment
More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of the groundbreaking WEB™ Aneurysm E...
2025-03-19 21:00
2136
"Miracle Doctor" Dr. Wei-Hua Chen: Role of Oligo Fucoidan in Cancer Care
LOS ANGELES, March 19, 2025 /PRNewswire/ -- Dr. Wei-Hua Chen, a renowned 70-year-old cardiologist and the director of Hongxin Clinic (Taichung,Taiwan), has been awarded the "28th Fervent Global Love of Lives Award 2025" by the Chou Ta-Kuan Cultural and Educational Foundation. First diagnosed with...
2025-03-19 20:00
1608
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
IRVINE, Calif., March 19, 2025 /PRNewswire/ -- Zymo Research Corporation acknowledges the recent ruling, onMarch 14, 2025, by the United States District Court for the Central District ofCalifornia in the ongoing litigation with QIAGEN GmbH. The Court has denied QIAGEN's Partial Motion to Dismiss ...
2025-03-19 19:00
1884
Launched at Breakthrough 2025, ArisGlobal announces LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs
ZURICH, March 19, 2025 /PRNewswire/ -- ArisGlobal, a leading life sciences technology company and creator ofLifeSphere®, today announced three new cutting-edge product offerings that will advance pharmacovigilance and regulatory operations. AtBreakthrough 2025, its annual industry event, the com...
2025-03-19 16:00
2017
Innovent and HUTCHMED Jointly Announce that the FRUSICA-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Has Met Its Primary Endpoint in Advanced Renal Cell Carcinoma in China
SAN FRANCISCO and SUZHOU, China, March 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...
2025-03-19 09:20
2555
CARsgen Announced 2024 Annual Results
SHANGHAI, March 18, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 Annual Results. Business Highlights * Zevor-cel was approved by China's National Medical Products Administra...
2025-03-19 08:15
4034
DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company's Prestigious Annual List of the World's Most Innovative Companies of 2025
NEW YORK, March 19, 2025 /PRNewswire/ -- DarwinHealth is proud to have been named toFast Company's prestigious list of the World's Most Innovative Companies of 2025. This year's list shines a spotlight on businesses that are shaping research, industry, and the human condition through their unique...
2025-03-19 05:45
2577
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the AI-powered analytics Platform SOP...
2025-03-18 21:00
2173
Bloomage Passes GMP Audit by South Korea's MFDS, Strengthening its Global Quality Assurance
PARSIPPANY, NJ., March 18, 2025 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has successfully passed the GMP on-site inspection bySouth Korea's Ministry of Food and Drug Safety (MFDS) with no observations of non-compliance. This certifica...
2025-03-18 21:00
2218
Vatech and Pearl Join Forces to Revolutionize Dental Diagnosis with AI Integration
HWASEONG, South Korea, March 18, 2025 /PRNewswire/ -- Vatech, a global leader in dental imaging solutions, and Pearl, a frontrunner in dental AI technology, have announced a collaborative alliance aimed at transforming the landscape of dental diagnosis. By integrating Pearl's advanced AI-powered ...
2025-03-18 21:00
2539
Lunit Secures Multi-Year Contract with UAE's Largest Healthcare Network to Power National AI Breast Cancer Screening Program
Strategic agreement to deploy Lunit INSIGHT MMG across SEHA's extensive healthcare network, analyzing over hundred thousand mammograms over five years SEOUL, South Korea, March 18, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and t...
2025-03-18 21:00
3283
A chronographic analysis of MSC's rollercoasting journey
TIANJIN, China, March 18, 2025 /PRNewswire/ -- On March 12, 2025, China's Center for Drug Evaluation (CDE) approved Tasly's Investigational New Drug (IND) application for NR-20201, an allogeneic adipose-derived mesenchymal stromal cell, sparking discussions about the historical development of me...
2025-03-18 20:00
2545
So-Young Reschedules Release of Fourth Quarter and Full Year 2024 Financial Results to March 28, 2025
BEIJING, March 18, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community inChina for consumers, professionals and service providers in the medical aesthetics industry, today announced that it has rescheduled the ...
2025-03-18 17:00
2922
Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension
This partnership aims to enhance ophthalmic care by providing better treatment for post-operative inflammation and pain in patients across 11 countries. TAIPEI, March 18, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (6838.TW) today announced an exclusive licensing agreement with Cipl...
2025-03-18 16:00
3893
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™
SINGAPORE, March 18, 2025 /PRNewswire/ -- HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHT™ – now available in the United States. This marks a significant milest...
2025-03-18 11:00
2580
Total Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics and R&D Projects for NTDs With Partners Including Drugs & Diagnostics for Tropical Diseases and Medical & Biological Laboratories
TOKYO, March 18, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximatelyJPY 1.7 billion ( USD 11.4 million1) in five projects for the development of schistosomiasis diagnostics and drugs for neglected tropical diseases (NTDs).2 ...
2025-03-18 10:42
1922
Anti-HER2 Biparatopic ADC JSKN003 Has Been Granted Breakthrough-Therapy Designation for the Treatment of PROC
SUZHOU, China, March 18, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Breakthrough Therapy Designation by the ...
2025-03-18 09:47
2385
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or 'ANVISA') has approved Illuccix® (kit fo...
2025-03-18 06:52
2869
Week's Top Stories
Most Reposted
UFO SIM Launches in Australia, The Ultimate Travel eSIM Starting at Just AU$2/GB
[Picked up by 310 media titles]
2026-04-01 11:03
Sustainable Tourism Impact Fund Expands Investments Across Southeast Asia
[Picked up by 309 media titles]
2026-04-03 11:30
Surfin Meta Digital Technology signs MOU with the Philippine Social Security System to explore digital financial service enhancements
[Picked up by 305 media titles]
2026-04-01 09:00
From Doomscroll to Page-Turner: BookXcess Launches The Brain Un-Rot Library to Help Rebuild a Generation's Focus
[Picked up by 302 media titles]
2026-03-31 13:53
DayOne Announces RM28+ Billion Commitment and Talent Initiatives in Malaysia at Inaugural Tech & AI Career Expo
[Picked up by 291 media titles]
2026-04-01 22:23
Most Read
MicroCloud Hologram Inc. Reports 39.1% Increase in Total Revenue for Fiscal 2025
2026-03-28 01:47
8007
Hitek Global Inc. Announces Pricing of $3 Million Registered Direct Offering
2026-03-28 01:29
7088
Health In Tech Announces Closing of $7.0 Million Private Placement
2026-03-28 04:00
7075